Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.
Octarine Bio has raised $5.9M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Octarine Bio's investors include The Footprint Firm, Unconventional Ventures, Vaekstfonden, MassChallenge, Edaphon.
Octarine Bio is headquartered in Copenhagen, Denmark.
Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry.
Octarine Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Octarine Bio — Funding & Investors." VCBacked, January 22, 2026, https://www.vcbacked.co/company/octarine-bio. Accessed October 17, 2026.
VCBacked. (2026). Octarine Bio — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/octarine-bio
{{cite web |title=Octarine Bio — Funding & Investors |url=https://www.vcbacked.co/company/octarine-bio |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated